What Is Nuchal Translucency? The Basics

If you have ever looked at a first-trimester ultrasound report and seen the words “nuchal translucency,” you are not alone in wondering what they mean. Nuchal translucency is a small pocket of fluid at the back of a developing baby’s neck that can be measured by ultrasound, usually between about 11 and 14 weeks of pregnancy. The measurement itself is not a diagnosis. It is a screening tool that helps estimate the chance of certain chromosomal conditions, most often Down syndrome (trisomy 21).

What Is Nuchal Translucency?

Nuchal translucency (often shortened to NT) is the collection of fluid under the skin at the back of the fetal neck. On an ultrasound image, it appears as a thin dark strip behind the neck. A trained sonographer measures the thickness of that strip in millimeters.

The measurement matters because, in general, a thicker NT is associated with a higher chance of certain chromosomal abnormalities. The most studied of these is trisomy 21, but the list also includes trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome). An increased NT can also be seen in some pregnancies with heart defects or other structural differences, even when the chromosomes are normal.

It is important to be clear about what NT is not. It is not a test that gives a yes or no answer. It does not diagnose a condition on its own. It shifts a probability up or down, which is why it is almost always combined with other information — maternal age, a blood test, and sometimes additional ultrasound findings — to produce a risk estimate.

When Is Nuchal Translucency Measured?

The NT measurement is done during a specific window, generally from about 11 weeks to 13 weeks and 6 days of pregnancy. This timing is not arbitrary. Before roughly 11 weeks, the fluid collection is not reliably visible or measurable. After about 14 weeks, the fluid tends to be reabsorbed, and the measurement is no longer meaningful.

Timing is measured from the first day of your last menstrual period, or from an early ultrasound dating scan if one was done. Because the window is narrow, scheduling matters. If you are considering this screening, it is worth asking your provider early in pregnancy about the timing so the appointment can be arranged within the correct range.

The measurement also depends on the skill of the person doing it and the quality of the equipment. Guidelines for this screening specify that sonographers should receive specific training and certification to perform it. A measurement taken by someone without that training may not be reliable.

How Is the Nuchal Translucency Measurement Taken?

The procedure is a standard abdominal ultrasound. You lie down, gel is applied to your belly, and a transducer is moved across the abdomen to get a clear view of the fetus. In some cases a transvaginal ultrasound is used instead, especially early in the window.

To get an accurate reading, the sonographer needs the fetus to be in a specific position — lying on its back, in a profile view, with the neck area clearly visible. The fetus also needs to be at a particular size, measured as crown-rump length, for the measurement to be valid. If the baby is in the wrong position, the appointment may need to be rescheduled.

The sonographer takes several measurements and uses the largest technically correct one. The result is reported in millimeters, and it is interpreted relative to what is expected for that specific crown-rump length. A raw number without that context does not mean much on its own.

What Does an Abnormal Nuchal Translucency Result Mean?

An NT measurement is considered increased when it is above a certain cutoff, which is usually defined relative to the fetal size rather than as one fixed number. When the measurement is higher than expected, it does not mean the baby definitely has a chromosomal condition. Most pregnancies with an increased NT still result in a baby without one.

What an increased NT does mean is that the chance is higher than average, and further testing is usually offered. That testing might include:

• Cell-free DNA screening (a blood test from the mother that analyzes placental DNA)
• Chorionic villus sampling (CVS), which takes a small sample of placental tissue
• Amniocentesis, which takes a small sample of amniotic fluid

CVS and amniocentesis are diagnostic tests, meaning they can confirm or rule out specific chromosomal conditions. They also carry a small risk of miscarriage, which is why they are not done routinely. Cell-free DNA screening is not diagnostic — it estimates risk — but it is increasingly used as a first step.

An increased NT can also prompt a closer look at the fetal heart, because some heart defects are associated with a thicker NT even when chromosomes are normal. In those cases, a detailed anatomy scan and possibly a fetal echocardiogram may be recommended later in pregnancy.

How Does Nuchal Translucency Fit Into First-Trimester Screening?

NT is rarely used alone. It is usually part of a combined first-trimester screening that also includes a blood test measuring two substances: pregnancy-associated plasma protein A (PAPP-A) and free beta-hCG. Together with maternal age and the NT measurement, these values produce a risk estimate for trisomy 21 and sometimes trisomy 18.

This combined approach has been the standard first-trimester screen for many years. More recently, cell-free DNA screening has become widely available and in many cases is more accurate for detecting trisomy 21. Some providers now offer cell-free DNA as a primary screen and use NT mainly to look for structural issues or as part of a broader assessment.

Which approach is best depends on your situation, your provider’s practice, and what is available to you. There is no single right answer for everyone, and it is reasonable to ask your provider why a particular test is being recommended.

What Are the Limits of Nuchal Translucency Screening?

NT screening has real limitations, and understanding them helps you interpret results honestly. It is a screening test, not a diagnostic one. A normal result does not guarantee a baby without a chromosomal condition, and an increased result does not mean a baby definitely has one.

Accuracy also depends on the quality of the measurement. Studies have shown that when NT is measured by untrained operators or with poor technique, results are less reliable. This is one reason professional guidelines emphasize certification and ongoing quality review for those performing the measurement.

NT also does not detect all chromosomal conditions. It is most closely tied to trisomy 21, 18, and 13. Other genetic conditions may not affect the NT measurement at all. And some pregnancies with an increased NT turn out to have no identifiable cause — the measurement was simply higher than expected, and the baby was born healthy.

If you receive an increased NT result, it is reasonable to ask for a referral to a genetic counselor or maternal-fetal medicine specialist. These professionals can explain what the number means in your specific situation and walk you through the options for further testing.

Is Nuchal Translucency Screening Right for You?

Whether to have NT screening is a personal decision. Some people want as much information as possible early in pregnancy. Others prefer to avoid testing that might lead to difficult decisions or anxiety. Both approaches are valid.

What matters is that you have accurate information about what the test can and cannot tell you. NT screening estimates risk. It does not provide certainty. If certainty is what you want, a diagnostic test like CVS or amniocentesis is the only way to get it — and those tests carry their own small risks.

If you are unsure, a conversation with your provider or a genetic counselor before the screening window closes can help you decide. The window is short, so it is worth having that conversation early.